Black Rock Inc. I Bio, Inc. Transaction History

Black Rock Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$0.23 - $160.0 $652,951 - $454 Million	2,838,918 Added 71.68%	6,799,636 $1.16 Million
Q2 2022 Aug 12, 2022	SELL	$0.23 - $0.46 $2.59 Million - $5.18 Million	-11,259,933 Reduced 73.98%	3,960,718 $1.05 Million
Q1 2022 May 12, 2022	SELL	$0.3 - $0.61 $76,809 - $156,179	-256,032 Reduced 1.65%	15,220,651 $6.52 Million
Q4 2021 Feb 10, 2022	SELL	$0.55 - $1.04 $22,185 - $41,950	-40,337 Reduced 0.26%	15,476,683 $8.5 Million
Q3 2021 Nov 09, 2021	SELL	$1.06 - $1.52 $38,496 - $55,201	-36,317 Reduced 0.23%	15,517,020 $16.4 Million
Q2 2021 Aug 11, 2021	BUY	$1.22 - $1.65 $19 Million - $25.7 Million	15,553,337 New	15,553,337 $23.5 Million

Ticker IBIO
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 9,006,580
Market Cap $23.8M
Description
iBio, Inc., a biotechnology company, provides contract development and manufacturing services to collaborators and third-party customers in the United States. The company operates in two segments: Biopharmaceuticals and Bioprocessing. Its lead therapeutic candidate is IBIO-100 that is being advanced for investigational new drug development for t...

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

Stay updated on Black Rock Inc. with notifications on news.